Compare ARK Genomic Revolution ETF (ARKG) vs Roundhill NVDA WeeklyPay ETF (NVDW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Roundhill NVDA WeeklyPay ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Roundhill NVDA WeeklyPay ETF trades at $36.32. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Roundhill NVDA WeeklyPay ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | NVDW | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $53.42 |
52-Week Low | $23.09 | $31.88 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
NVDW trades at $37.56, up 4.71% today, but technical indicators signal bearish momentum with selling pressure outweighing buying signals. The stock faces resistance near $38-39 while finding support around $35-33. Recent dividend activity shows frequent but variable payouts, with Seeking Alpha noting the ETF's quasi-synthetic leveraged position in Nvidia generates fluctuating income streams.
The outlook remains cautious due to technical bearish signals and payout volatility. Investment opportunity exists for income-focused investors seeking Nvidia exposure, but risks include dependency on NVDA performance and significant weekly dividend fluctuations that challenge yield predictability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Roundhill NVDA WeeklyPay ETF
NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →
